Moody's Investors Service, ("Moody's") today affirmed Dentsply Sirona Inc.'s Baa2 senior unsecured rating, its Baa2 issuer rating and Prime-2 Commercial Paper rating. Moody's also assigned a Baa2 rating to the company's proposed offering of senior unsecured notes.

Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

A manufacturer that produces medical equipment for dentistry is halting operations due to the effects of coronavirus on the industry.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY), which is in the medical equipment business, and is based in United States, saw a...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see DENTSPLY...

H.C. Wainwright analyst Yi Chen reiterated a Hold rating on DENTSPLY SIRONA (NASDAQ:XRAY) Inc on Monday, setting a price target of $38, which is approximately 6.52% below the present share price of $40.65.

Former US vice president's firm releases 1st-quarter portfolio Continue reading...

U.S. payroll numbers in March were lackluster. We have highlighted a few industries that survived the coronavirus threat in March and also the ones that succumbed.

Shares of Dentsply Sirona (NASDAQ:XRAY) rose 2% after the company reported Q1 results.Quarterly Results Earnings per share were down 12.24% year over year to $0.43, which beat the estimate of $0.38.Revenue of $874,300,000 lower by 7.60% year over year, which beat the estimate of $867,830,000.Outlook Earnings guidance hasn't been issued by the company for now.Revenue guidance hasn't been issued by the company for now.Details Of The Call Date: May 08, 2020View more earnings on XRAYWebcast URL: https://edge.media-server.com/mmc/p/i8cubptqRecent Stock Performance Company's 52-week high was at $60.87Company's 52-week low was at $31.57Price action over last quarter: down 10.61%Company Description Dentsply Sirona is one of the world's largest manufacturers and distributors of dental supplies and equipment. Its product segments include dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. The majority of its products are sold through dental distributors, and over approximately 65% of Dentsply's sales are outside the U.S.See more from Benzinga * Recap: Pinnacle West Capital Q1 Earnings * Lear: Q1 Earnings Insights * Switch: Q1 Earnings Insights(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

DENTSPLY SIRONA (XRAY) first-quarter performance to reflect focus on product innovation and R&D.

Dentsply (XRAY) delivered earnings and revenue surprises of 4.88% and -0.29%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Dentsply Sirona Inc. New York, May 21, 2020 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Dentsply Sirona Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (XRAY), the Dental Solutions Company, today announced that it will participate in the Stifel 2020 Jaws and Paws Conference on May 27th. Don Casey, Chief Executive Officer, will represent the company and is scheduled to participate in a fireside chat at 4:45PM Eastern Time. A replay of the presentation will also be available on the Dentsply Sirona website at www.dentsplysirona.com.

DENTSPLY SIRONA's (XRAY) first-quarter 2020 preliminary results reflect weak segmental performance and decline in revenues.

Reported net sales of $874.3 million, down 7.6% in the first quarter. Organic sales declined 4.3%Reported operating loss was $124.8 million and operating margin was negative.

CHARLOTTE, N.C., May 01, 2020 -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and.

XRAY earnings call for the period ending March 31, 2020.

Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CHARLOTTE, N.C., May 21, 2020 -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY), The Dental Solutions Company™, announced that its Board of Directors declared a.

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]